NOT-CA-11-005: NCI Will Participate in RFA-HG-11-003, Development of a Preliminary Evidence Base to Inform Decision-making about Returning Research Results to Participants in Genomic Studies (R01)

NCI Will Participate in RFA-HG-11-003, "Development of a Preliminary Evidence Base to Inform Decision-making about Returning Research Results to Participants in Genomic Studies (R01)"

Notice Number: NOT-CA-11-005

Key Dates

Release Date: January 3, 2011

Issued by

National Cancer Institute (NCI)

Purpose

This Notice is to inform potential applicants that the National Cancer Institute (NCI) will participate in Request for Application (RFA) RFA-HG-11-003, entitled Development of a Preliminary Evidence Base to Inform Decision-making about Returning Research Results to Participants in Genomic Studies (R01)," effective immediately.

Catalog of Federal Domestic Assistance Number:
93.399

The Components of Participating Organizations section of RFA-HG-11-003 has been revised to include NCI:

Components of Participating Organizations

National Human Genome Research Institute (NHGRI)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Cancer Institute (NCI)

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Sheri Schully, Ph.D.
Epidemiology and Genetics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Boulevard, EPN Room 5124, MSC 7393
Bethesda, MD 20892-7393 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-U.S.P.S. delivery)
Telephone: (301) 435-4911
E-mail: [email protected]